Kura Oncology, Inc.KURA
Price (close)
$10.86
Market cap
$966.1M
P/E
—
Revenue (TTM)
$77.2M
Net income
-$296.8M
Dividend yield
—
1-year total return
29.9%
Net margin
-384.3%
Revenue growth
—
Debt / equity
0.20x
What Kura Oncology, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $53.9M | $67.5M |
| Net income | -$89.6M | -$130.5M | -$135.8M | -$152.6M | -$174.0M | -$278.7M |
| Free cash flow | -$72.0M | -$105.7M | -$110.7M | -$125.0M | $133.8M | -$70.7M |
More on KURA.
- Kura Oncology, Inc. summary
- Kura Oncology, Inc. financial statements
- Kura Oncology, Inc. key metrics
- Kura Oncology, Inc. health scores and style box
- Kura Oncology, Inc. earnings
- Kura Oncology, Inc. dividends
- Kura Oncology, Inc. valuation
- Kura Oncology, Inc. ownership and insiders
- Kura Oncology, Inc. peers
Figures from Kura Oncology, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.